alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,801–2,825 of 27,380 studies, newest first · page 113 of 1096.

October 2025 25

  1. 2025-10-31

    Roles of TREM2 in Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Translational neurodegeneration

    Key finding: Variants in the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been demonstrated to increase the risk of late-onset Alzheimer's disease (AD) and Nasu-Hakola disease.

    Full summary, score breakdown and related studies → Original source

  2. 2025-10-31

    A Cohort Study on Alzheimer's Disease in Relation to Residential Magnetic Fields From Indoor Transformer Stations

    ✓ Peer-reviewed Health systems and care delivery Bioelectromagnetics

    Key finding: Meta-analyses of epidemiological studies have suggested that Alzheimer's disease (AD) may be linked with exposure to extremely low frequency (ELF) magnetic fields (MF). +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2025-10-31

    GUIDE and Beyond: Strategies for Comprehensive Dementia Care Integration

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Geriatrics Society

    Key finding: Drawing from the experiences of six previously tested programs-Aging Brain Care, Alzheimer's and Dementia Care, BRI Care Consultation, Care Ecosystem, Integrated Memory Care, and MIND at Home-we describe a four-step approach to enable successful adoption and implementation: identifying key leaders and partners, preparing a tailored value proposition, initiating program start-up, and ensuring sustainable implementation. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2025-10-31

    Behavioral Challenges and Adaptive Strategies in Providing Mealtime Care to Residents With Dementia: A Qualitative Study of Nursing Home Clinical and Administrative Staff

    ✓ Peer-reviewed Clinical safety Journal of Applied Gerontology

    Key finding: This study examined how nursing home staff adapt to challenging mealtime behaviors in residents with dementia, such as turning away or refusing food.

    Full summary, score breakdown and related studies → Original source

  5. 2025-10-31

    Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in Cellular Neuroscience

    Key finding: In particular, it clarifies whether the cooperation of non-coding RNAs with amyloid and tau protein enhances neuroinflammation and whether the vicious cycle of neuroinflammatory responses affects the production, behavior, and aggregation of these molecules. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2025-10-31

    Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both?

    ✓ Peer-reviewed Inflammation and the immune system Developmental Neurobiology

    Key finding: Microglia, the resident immune cells of the central nervous system, and astrocytes, key regulators of homeostasis and neurotransmission, undergo significant phenotypic changes in response to AD pathology.

    Full summary, score breakdown and related studies → Original source

  7. 2025-10-31

    Alzheimer Syndrome or Age-Related Dementia—History, Therapy and Prevention

    ✓ Peer-reviewed Brain tissue and pathology Journal of Clinical Medicine

    Key finding: This new nosology has been widely criticized, given the absence of curative therapy, the evidence of mixed pathology in most cases and the decline in the dementia/AD incidence in high-income countries. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2025-10-31

    Identifying potential drug targets for cerebral amyloid angiopathy: A Mendelian randomization study based on the druggable genes

    ✓ Peer-reviewed Brain tissue and pathology Medicine

    Key finding: Cis-expression quantitative trait locus (cis-eQTL) of druggable genes from eQTLGen Consortium and genome-wide association study of CAA from FinnGen database were used to screen for drug-usable genes causally associated with CAA. +3 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2025-10-31

    TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD

    ✓ Peer-reviewed Brain tissue and pathology Nature Neuroscience

    Key finding: Using iPSC-derived neurons and postmortem ALS/FTD brain and spinal cord tissue we find widespread, disease-specific and TDP-43-specific skipping of an exon encoding the KCNQ2 pore domain. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2025-10-31

    Examining neuropsychiatric symptoms and functional decline in behavioral variant frontotemporal dementia

    ✓ Peer-reviewed Lewy body dementia International Review of Psychiatry

    Key finding: Impairments in transactions (47%) and verbal communication (44%) were common at baseline, while impairments in self-care and incontinence ( 40%). +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2025-10-31

    Lecanemab, Donanemab, and Emerging Disease Modifying Therapies for Alzheimer Disease: Clinical Evidence and Primary Care Implications in Canada

    ✓ Peer-reviewed Treatments International Journal of Science and Research Archive

    Key finding: Monoclonal antibodies such as lecanemab and donanemab show reduction in amyloid plaque and slowing of cognitive and functional decline (modest) in early AD (mild cognitive impairment or mild dementia). +4 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2025-10-31

    Lecanemab, Donanemab, and Emerging Disease Modifying Therapies for Alzheimer Disease: Clinical Evidence and Primary Care Implications in Canada

    ✓ Peer-reviewed Treatments International Journal of Science and Research Archive

    Key finding: Monoclonal antibodies such as lecanemab and donanemab show reduction in amyloid plaque and slowing of cognitive and functional decline (modest) in early AD (mild cognitive impairment or mild dementia). +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2025-10-31

    Lecanemab, Donanemab, and Emerging Disease Modifying Therapies for Alzheimer Disease: Clinical Evidence and Primary Care Implications in Canada

    ✓ Peer-reviewed Treatments International Journal of Science and Research Archive

    Key finding: Monoclonal antibodies such as lecanemab and donanemab show reduction in amyloid plaque and slowing of cognitive and functional decline (modest) in early AD (mild cognitive impairment or mild dementia). +4 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2025-10-30

    Alpha-synuclein deposition patterns in Alzheimer's disease: association with cortical amyloid beta and variable tau load

    ✓ Peer-reviewed Brain tissue and pathology Acta neuropathologica

    Key finding: Relationships with age, sex, and ApoE genotype were examined. α-syn co-pathology was detected in 60% of AD cases, more frequently, although not significantly, in women. +3 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2025-10-30

    Exercise and the blood-brain barrier: Mechanistic insights and therapeutic implications

    ✓ Peer-reviewed Prevention trials Neurobiology of disease

    Key finding: In recent years, exercise, as a low-cost and low-side-effect non-pharmacological intervention, has demonstrated significant potential in modulating the structure and function of the BBB. +1 more finding

    Full summary, score breakdown and related studies → Original source

  16. 2025-10-30

    Performance of blood biomarkers in internal jugular vein for Alzheimer's disease pathologies: the Delta Method study

    ✓ Peer-reviewed Biomarkers Science bulletin

    Key finding: The results showed that the levels of Aβ42, Aβ40, p-tau217, p-tau181, GFAP, and NfL were higher in the IJV than in MCV and were highly correlated between the two sites. +3 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2025-10-30

    Association between different dietary patterns and the risk of major brain disorders: a prospective multi-cohort study

    ✓ Peer-reviewed Prevention trials EClinicalMedicine

    Key finding: In the UK Biobank cohort (N = 166,916), MIND diet demonstrated the broadest neuroprotective effects. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2025-10-30

    The brain neurovascular epigenome and its association with dementia

    ✓ Peer-reviewed Inflammation and the immune system Neuron

    Key finding: Cerebral small vessel disease (SVD) is frequently comorbid with Alzheimer's disease (AD), and brain endothelial cells (BECs) express genes associated with AD genetic risk. +3 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2025-10-30

    Psychological distress and cultural role conflict among dementia family caregivers in China: a phenomenological study

    ✓ Peer-reviewed Caregiving BMC Nursing

    Key finding: Four themes emerged: layered caregiving burden, cultural strain and emotional dissonance, dual emotional experiences of caregiving, and coping strategies and unmet needs. +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2025-10-30

    rs140926439 Variant in the Fibronectin FN1 Gene Lowers Risk of Alzheimer Disease in APOEε4 Carriers in the UK Biobank Cohort

    ✓ Peer-reviewed Genetics Alzheimer Disease & Associated Disorders

    Key finding: When rs140926439 was absent, 0.10% of APOEε2/3 carriers had AD, while 0.43% of APOEε4 carriers or homozygotes had AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2025-10-30

    Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p‐tau217, and p‐tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohort

    ✓ Peer-reviewed Biomarkers Alzheimer s & Dementia

    Key finding: The preanalytical delay has a significant impact for Aβ40 and Aβ42. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2025-10-30

    Association between vaccinations and risk of dementia: a systematic review and meta-analysis

    ✓ Peer-reviewed Prevention and risk Age and Ageing

    Key finding: Adult vaccinations, particularly against herpes zoster, influenza, pneumococcus and Tdap, are associated with a lower risk of dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2025-10-29

    A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease

    ✓ Peer-reviewed Clinical trials Journal of Alzheimer's disease : JAD

    Key finding: BackgroundPreclinical and clinical evidence suggest that low-dose cannabinoids could ameliorate Alzheimer's disease (AD) signs and symptoms. +2 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2025-10-29

    Effect of Intensive Systolic Blood Pressure Control on Markers of Cerebral Small Vessel Disease by Age

    ✓ Peer-reviewed Vascular contributions Hypertension

    Key finding: In SPRINT, the overall interaction between age and SBP on WMHv change was not statistically significant ( P =0.18). +4 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2025-10-29

    Neuropathologic Changes in People With Essential Tremor With Dementia

    ✓ Peer-reviewed Disease mechanisms Neurology

    Key finding: Other neuropathologies were similar across cognitive groups. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →